Aethlon Medical Inc. (AEMD)
0.36
-0.01 (-1.83%)
At close: Mar 31, 2025, 12:16 PM
Aethlon Medical Inc. Revenue Breakdown
| Quarter | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Sep 30, 2018 | Jun 30, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|
| Aethlon Revenue | 13.12K | 34.23K | 206.73K | 149.63K | 149.63K | 74.81K |
| Aethlon Revenue Growth | -61.69% | -83.44% | +38.16% | 0.00% | +100.00% | n/a |
| E S I Revenue | 0 | n/a | n/a | n/a | n/a | n/a |
| E S I Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Quarter | Mar 31, 2014 |
|---|---|
| Milestonetwopointthreepointtwopointtwoothermember Revenue | 195.58K |
| Milestonetwopointthreepointtwopointtwoothermember Revenue Growth | n/a |
| Milestone M3 Revenue | 195.58K |
| Milestone M3 Revenue Growth | n/a |
| Milestone M5 Revenue | 208.78K |
| Milestone M5 Revenue Growth | n/a |
Operating Expense Breakdown
| Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.81M | 2.9M | 2.62M | 1.76M | 2.69M | 3.18M | 3.41M | 3.05M | 2.85M | 3.67M | 2.91M | 3.8M | 2.55M | 2.14M | 2.23M | 2.3M | 3.07M | 1.77M | 1.41M | 1.99M | 1.29M | 1.7M | 1.6M | 1.67M | 1.96M | 1.35M | 1.25M | 1.35M | 1.24M | 1.24M | 1.16M | 1.5M | 1.24M | 2.61M | 1.14M | 1.29M | 1.39M | 1.31M | 1.28M | 1.33M |
| Selling, General, and Administrative Revenue Growth | -37.47% | +10.73% | +49.31% | -34.85% | -15.15% | -6.83% | +11.66% | +7.10% | -22.25% | +26.13% | -23.50% | +49.26% | +18.89% | -4.02% | -2.98% | -25.10% | +73.27% | +25.59% | -29.19% | +54.43% | -24.22% | +6.64% | -4.47% | -14.92% | +45.80% | +8.02% | -7.35% | +8.68% | +0.18% | +6.54% | -22.87% | +21.75% | -52.74% | +130.06% | -11.99% | -6.80% | +5.52% | +2.36% | -3.67% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | 644.89K | 593.4K | 628.45K | 678.92K | 615.62K | 558.22K | 852.46K | 858.35K | 937.11K | 354.57K | 478.2K | 587.69K | 704.67K | 461.18K | 508.9K | 377.17K | 234.98K | 218.57K | 222.86K | 248.87K | 240.24K | 243.84K | 178.8K | 194.78K | 123.36K | 129.21K | 168.57K | 157.46K | 175.93K | 178.44K | 280.86K | 117.66K | 205.81K | 147.8K | 207.68K | 182K | 280.34K |
| Research and Development Revenue Growth | n/a | n/a | -100.00% | +8.68% | -5.58% | -7.43% | +10.28% | +10.28% | -34.52% | -0.69% | -8.40% | +164.29% | -25.85% | -18.63% | -16.60% | +52.80% | -9.38% | +34.93% | +60.51% | +7.51% | -1.92% | -10.45% | +3.59% | -1.48% | +36.38% | -8.21% | +57.90% | -4.52% | -23.35% | +7.05% | -10.49% | -1.41% | -36.47% | +138.70% | -42.83% | +39.25% | -28.83% | +14.11% | -35.08% | n/a |